are glp 1 covered by medicare GLP-1 Drug Coverage π¨ BIG NEWS FOR MEDICARE
Description
doi: 10.3389/FPHAR.2025.1517272/FULL 129 BonfioliGBRodellaLMetraMVizzardiE
Fragmented care, such as receiving prescriptions from specialists without informing primary care providers, can further disrupt continuity in therapy
A meta-analysis of 19 RCTs suggests short term improvement in A1C that is not sustained after 3 months and associated with higher incidence of GI side effects (75)
Here are 8 potential reasons why not to prescribe Lixisenatide: 1- this is only one small study and only one dose was tested, 2- Lixisenatide is not currently available at pharmacies, 3- the weight loss associated with this GLP-1 is not desirable in many cases of Parkinsons disease where weight loss is an issue, 4- non-motor outcomes did not change as in other trials, and this will need to be better explained
For decades, obesity pharmacology was constrained by single-pathway thinking: block appetite here, improve insulin there
Husk ogs at bonuser er frivillige
